| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/07/2009 | CA2517622C Veterinary compositions for treating mastitis |
| 04/07/2009 | CA2511255C 2-piperidone derivatives as prostaglandin agonists |
| 04/07/2009 | CA2502103C Colon cleansing compositions |
| 04/07/2009 | CA2498291C Diazabicyclic compounds useful in the treatment of cns and other disorders |
| 04/07/2009 | CA2493633C Kinase inhibitors |
| 04/07/2009 | CA2490152C Oxazole derivatives and their use as insulin sensitizers |
| 04/07/2009 | CA2485656C Device for the transdermal administration of a rotigotine base |
| 04/07/2009 | CA2463815C Pharmaceutically acceptable alendronate salts in amorphous form |
| 04/07/2009 | CA2463294C Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/07/2009 | CA2458684C Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 04/07/2009 | CA2450858C Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-.alpha.,.alpha.-dimethylbenzene acetic acid and its hydrochloride |
| 04/07/2009 | CA2437743C Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 04/07/2009 | CA2436438C 4-aminobenzopyran derivatives |
| 04/07/2009 | CA2430814C A process for the preparation of paclitaxel |
| 04/07/2009 | CA2416706C Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 04/07/2009 | CA2416624C Treatment of arthritis and compositions therefore |
| 04/07/2009 | CA2415890C N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/07/2009 | CA2410065C Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/07/2009 | CA2407345C 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol |
| 04/07/2009 | CA2400554C Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 04/07/2009 | CA2393757C Cycloamine ccr5 receptor antagonists |
| 04/07/2009 | CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 04/07/2009 | CA2387888C Local prevention or amelioration of pain from surgically closed wounds |
| 04/07/2009 | CA2383583C Benzopyran derivative |
| 04/07/2009 | CA2377147C New indolocarbazole alkaloids from a marine actinomycete |
| 04/07/2009 | CA2376033C Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy |
| 04/07/2009 | CA2373880C Isoquinoline derivatives or salts thereof |
| 04/07/2009 | CA2362833C Phenylalaninol derivatives |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2355774C Fibre blend for enteral composition |
| 04/07/2009 | CA2352505C Epothilone derivatives and their use as antitumor agents |
| 04/07/2009 | CA2352503C Il-5 inhibiting 6-azauracil derivatives |
| 04/07/2009 | CA2341991C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 04/07/2009 | CA2341968C Pyrrolobenzodiazepine compounds |
| 04/07/2009 | CA2341471C Pyrrolbenzodiazepines |
| 04/07/2009 | CA2339253C Inhibitors of p38 |
| 04/07/2009 | CA2330487C Administration of resveratrol to prevent or treat restenosis following coronary intervention |
| 04/07/2009 | CA2312856C Use of ginkgo biloba extracts for preparing a medicine |
| 04/07/2009 | CA2311643C Compositions and methods for inducing gene expression |
| 04/07/2009 | CA2300424C Hiv nuclear localization inhibitors |
| 04/07/2009 | CA2297112C Dicyclanil polymorphs and hydrates and their preparation |
| 04/07/2009 | CA2297097C Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 04/07/2009 | CA2294950C Levobupivacaine and its use |
| 04/07/2009 | CA2294921C Levobupivacaine and its use |
| 04/07/2009 | CA2281133C Multiple-agents-binding compound and use thereof |
| 04/07/2009 | CA2279402C Oil or fat composition containing phytosterol |
| 04/07/2009 | CA2276278C Amine compounds, their production and use |
| 04/07/2009 | CA2267947C Preparation of 3-fluoro oxindole derivatives |
| 04/07/2009 | CA2256633C Selected derivatives of k-252a |
| 04/07/2009 | CA2247558C Surfactant free rinse-off skin conditioning formulation |
| 04/07/2009 | CA2237157C Cyclopeptolide inhibitors of adhesion molecules |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/07/2009 | CA2210252C Crystalline trimetrexate salts and the process for making the same |
| 04/07/2009 | CA2208519C Viral vector complexes having adapters of predefined valence |
| 04/07/2009 | CA2204652C Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
| 04/07/2009 | CA2176716C Preparation of biodegradable microparticles containing a biologically active agent |
| 04/07/2009 | CA2174494C Benzofurans |
| 04/07/2009 | CA2118239C 1h-imidazo{4,5-c}quinolin-4-amines as vaccine adjuvants |
| 04/05/2009 | CA2644733A1 Method for alleviating keratoconjunctivitis sicca |
| 04/05/2009 | CA2639895A1 Energizing compositions comprising goji, red clover and polygonum multiflorum, and uses thereof |
| 04/02/2009 | WO2009042972A1 Fluorinated lipids and methods of use |
| 04/02/2009 | WO2009042970A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 04/02/2009 | WO2009042962A2 Antidotes for factor xa inhibitors and methods of using the same |
| 04/02/2009 | WO2009042907A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | WO2009042859A1 Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell 1 |
| 04/02/2009 | WO2009042854A1 Ion-channel regulator compositions and methods of using same |
| 04/02/2009 | WO2009042815A1 Methods for treatment of cancer |
| 04/02/2009 | WO2009042809A1 Stable imatinib compositions |
| 04/02/2009 | WO2009042806A1 Polo-like kinase inhibitors |
| 04/02/2009 | WO2009042803A1 Imatinib compositions |
| 04/02/2009 | WO2009042778A1 Controlled release pharmaceutical compositions |
| 04/02/2009 | WO2009042733A1 Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate |
| 04/02/2009 | WO2009042729A1 Modulation of mglur signaling and methods of use in neurological and psychiatric diseases |
| 04/02/2009 | WO2009042711A1 Polo-like kinase inhibitors |
| 04/02/2009 | WO2009042694A1 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating |
| 04/02/2009 | WO2009042677A2 Stat3 inhibiting compositions and methods |
| 04/02/2009 | WO2009042668A2 Urea-containing peptides as inhibitors of viral replication |
| 04/02/2009 | WO2009042632A2 Combination therapy related to serotonin dual action compounds |
| 04/02/2009 | WO2009042625A1 Pharmaceutical compositions for administering oligonucleotides |
| 04/02/2009 | WO2009042618A1 Therapies for treating cancer using combinations of cox-2 inhibitors and anti-her2(erbb2) antibodies or combinations of cox-2 inhibitors and her2(erbb2) receptor tyrosine kinase inhibitors |
| 04/02/2009 | WO2009042613A1 Combination therapy for the treatment of cancer using cox-2 inhibitors and dual inhibitors of egfr [erbb1] and her-2 [erbb2] |
| 04/02/2009 | WO2009042612A1 Therapies for treating cancer using combinations of cox-2 inhibitors and aromatase inhibitors or combinations of cox-2 inhibitors and estrogen receptor antagonists |
| 04/02/2009 | WO2009042607A1 Thiazolopyrimidine p13k inhibitor compounds and methods of use |
| 04/02/2009 | WO2009042565A2 Inhibitors of eppin/semenogelin binding as male contraceptives |
| 04/02/2009 | WO2009042544A1 Quinone derivatives, pharmaceutical compositions, and uses thereof |
| 04/02/2009 | WO2009042543A1 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase |
| 04/02/2009 | WO2009042542A1 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 04/02/2009 | WO2009042485A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity |
| 04/02/2009 | WO2009042444A2 Methods and compounds for treating retinol-related diseases |
| 04/02/2009 | WO2009042440A1 1-methyl nicotinamide and derivatives for treatment of gastric injury |
| 04/02/2009 | WO2009042435A1 Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
| 04/02/2009 | WO2009042402A2 Composition and method for treating rosacea |
| 04/02/2009 | WO2009042395A1 Compositions comprising quinolone and methods for treating or controlling infections |
| 04/02/2009 | WO2009042377A1 Pharmacological adjunctive treatment associated with glaucoma filtration surgery |
| 04/02/2009 | WO2009042294A2 Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof |
| 04/02/2009 | WO2009042270A2 Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity |
| 04/02/2009 | WO2009042230A1 ß-GLUCAN TREATMENT OF UPPER RESPIRATORY TRACT INFECTION SYMPTOMS AND PSYCHOLOGICAL WELL-BEING |
| 04/02/2009 | WO2009042213A1 Methods of treating or preventing cardiac disease associated with a high fat diet |
| 04/02/2009 | WO2009042200A1 Solid forms comprising 3-(2,5-dimethyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, compositions comprising the same, and methods of using the same |
| 04/02/2009 | WO2009042193A1 Octahydropentalene compounds as chemokine receptor antagonists |